Endevica Bio Spins Off New Company to Develop Weight Loss Drug

The company, called Abisati, will focus solely on 710GO, an oral MC4R agonist that is effective in nonhuman primates and rats. Northbrook, Ill., Nov. 1, 2024 /PRNewswire/ -- Endevica Bio, a privately held company developing first-in-class peptide drug candidates, today announced the...